Comparison between Bio Medica Laboratories IPO and Logiciel Solutions IPO.
Bio Medica Laboratories IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Logiciel Solutions IPO is a SME Bookbuilding proposed to list at BSE SME.
| Bio Medica Laboratories IPO | Logiciel Solutions IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Fintellectual Corporate Advisors Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Prabhat Financial Services Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Bio Medica Laboratories IPO is up to ₹0.00 Cr whereas the issue size of the Logiciel Solutions IPO is up to ₹37.90 Cr. The final issue price of Bio Medica Laboratories IPO is and of Logiciel Solutions IPO is ₹193.00 per share.
| Bio Medica Laboratories IPO | Logiciel Solutions IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹183.00 per share | |
| Issue Price (Upper) | ₹193.00 per share | |
| Issue Price (Final) | ₹193.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 600 shares | |
| Fresh Issue Size | 32,05,200 shares | 15,90,600 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹30.70 Cr |
| OFS Issue Size | 3,76,800 shares | 3,73,200 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹7.20 Cr |
| Issue Size Total | 35,82,000 shares | 19,63,800 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹37.90 Cr |
Bio Medica Laboratories IPO opens on , while Logiciel Solutions IPO opens on Nov 28, 2025. The closing date of Bio Medica Laboratories IPO and Logiciel Solutions IPO is , and Dec 02, 2025, respectively.
| Bio Medica Laboratories IPO | Logiciel Solutions IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Nov 28, 2025 | |
| Issue Close | Dec 02, 2025 | |
| Basis Of Allotment (Tentative) | Dec 03, 2025 | |
| Initiation of Refunds (Tentative) | Dec 04, 2025 | |
| Credit of Share (Tentative) | Dec 04, 2025 | |
| Listing date (Tentative) | Dec 05, 2025 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bio Medica Laboratories IPO P/E ratio is , as compared to Logiciel Solutions IPO P/E ratio of 20.35.
| Bio Medica Laboratories IPO | Logiciel Solutions IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Bio Medica Laboratories Ltd.'s revenue increased by 150% and profit after tax (PAT) rose by 292% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Logiciel Solutions Ltd.'s revenue increased by 24% and profit after tax (PAT) rose by 38% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 82.78 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 20.35 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹144.13 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 99.59 | 32.80 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 48.20 | 31.95 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.02 | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 99.59 | 32.80 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Bio Medica Laboratories IPO Retail Individual Investors (RII) are offered 0 shares while in Logiciel Solutions IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Bio Medica Laboratories IPO and 1,00,200 shares in Logiciel Solutions IPO.
| Bio Medica Laboratories IPO | Logiciel Solutions IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 1,89,600 shares | 1,03,800 shares |
| QIB | 0 shares | 1,00,200 shares |
| NII | 0 shares | 9,28,800 shares |
| RII | 0 shares | 9,34,800 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 19,63,800 shares |
Bio Medica Laboratories IPO subscribed in total, whereas Logiciel Solutions IPO subscribed 2.04x.
| Bio Medica Laboratories IPO | Logiciel Solutions IPO | |
|---|---|---|
| QIB (times) | 1.32x | |
| NII (times) | 0.73x | |
| Big NII (times) | 0.43x | |
| Small NII (times) | 1.32x | |
| RII (times) | 3.43x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.04x |
